Focus: Align Technology is a publicly traded medical device company specializing in teeth alignment solutions, with $3.9B in FY2025 revenue and dominant market position in clear aligner therapy.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Align Technology to get notified when they start hiring — the background below is worth knowing for when they do.
Flagship product driving majority of revenue and company valuation; represents the core competitive moat.
Help build intelligence for Align Technology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Align Technology's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Product line extension addressing specific orthodontic indication; signals company strategy to expand indication footprint.
Align Technology Q1 2026 revenue down 0.7% to USD 1,040.1M - Medical Buyer
Align Technology Q1 2026 revenue down 0.7% to USD 1,040.1M Medical Buyer
CMS and FDA Announce RAPID Coverage Pathway to Accelerate Patient Access to Life-Changing Medical Devices
CMS and FDA announce the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway, a new pathway designed to expedite access to certain FDA-designated Class II and Class III Breakthrough Devices for people with Medicare.
Align Technology Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Align Technology Experiences Revision in Stock Evaluation Amid Mixed Market Indicators Markets Mojo
2X Names Emily Atkinson Chief Client Officer to Operationalize Its Unified GTM Engine - Customer Think
2X Names Emily Atkinson Chief Client Officer to Operationalize Its Unified GTM Engine Customer Think
Align Technology Opens with 6.07% Gain, Outperforming S&P 500's 2.51% Rise - Markets Mojo
Align Technology Opens with 6.07% Gain, Outperforming S&P 500's 2.51% Rise Markets Mojo
2X Appoints Emily Atkinson as Chief Client Officer - citybiz
2X Appoints Emily Atkinson as Chief Client Officer citybiz
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo